Form D · Pharmaceuticals
Ikano Therapeutics Inc.
Saddle Brook, NJ · CIK 0001395002
Offering snapshot reported Dec 9, 2009 · SEC filing
- Reported sold
- $893K Indefinite offering
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 25, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 9, 2009 | Initial | $892,719 | No comparison | 14 | SEC filing |
| Mar 5, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 17, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 15, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-101585
Source: Form D, filed Dec 9, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| G. Steven Burrill | Director |
| Pat Fabbio | Executive |
| Bruce Peacock | Director |
| Michael Ross | Director |
| James Tullis | Director |
| Robert Weisskoff | Director |
| Peter Young | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Park 80 West Plaza Two, Suite 310 250 Pehle Avenue
Saddle Brook, NJ, 07830
Saddle Brook, NJ, 07830